resources
From continuing education to podcasts by our team of experts, keep up with the latest at Children's Health.
RESEARCH & INNOVATION
transforming pediatric health care
Neurology
Retethering risk after filum terminale surgery: Insights from a large meta-analysis
To better inform surgical decision-making and optimize outcomes, experts at Children’s Health℠ conducted the largest and most comprehensive systematic review and meta-analysis to date of pediatric patients undergoing surgery for TFT or FFT.
Neurology
First-in-kind study validates safety of thalamic sampling during SEEG in Children with DRE
New study at Children’s Health confirms the safety of sampling thalamic nuclei during SEEG in pediatric patients with drug-resistant epilepsy (DRE). The findings revealed that accurate thalamic mapping can improve neuromodulation targeting.
Neurology
Case study: Are hybrid ORs the new gold-standard for neurosurgery?
Case study: A child with a giant cerebral aneurysm needed surgery to avoid a catastrophic rupture. A new, hybrid OR at Children’s Health was used to prevent delays, reduce risks and achieve an extraordinary outcome.
Neurology
3 Laser Ablation Applications that Truly Change the Game in Pediatric Neurosurgery
Pediatric laser ablation expert and neurosurgeon Angela Price, M.D., shares the latest advances, best practices and case studies from Children’s Health.
Neurology, +2 more
Benefits of Early Intervention and Coordinated Care for Kids With DMD
The Duchenne Muscular Dystrophy Clinic at Children's Health brings together a multidisciplinary team to improve the quality of their patients’ lives. See how.
Neurology
Supporting neurodevelopment of pediatric heart patients: 4 new initiatives
Children with heart conditions – especially those who need open-heart surgeries – are more likely to have cognitive, developmental, socio-emotional and behavioral challenges that impact their quality of life.
Neurology
4 classes of medications that will transform Duchenne muscular dystrophy care
Learn the latest research on gene replacement therapy, exon-skipping therapies, steroid alternatives and an allogeneic cardiosphere-derived cell therapy.
Neurology
New therapy uses SEEG monitoring and neuromodulation to reduce seizures
Innovative neurological monitoring at Children’s Health looks at which areas of the thalamus are involved in a child’s seizure network. The new approach combines SEEG with response neurostimulation to reduce seizures in kids with intractable epilepsy
Neurology
Focal Cerebral Arteriopathy Steroid (FOCAS) Trial
This trial in children with suspected focal cerebral arteriopathy (FCA) presenting with arterial ischemic stroke (AIS) or transient ischemic attack (TIA) comparing early corticosteroid treatment versus delayed/no corticosteroid treatment.
Neurology
Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea
The study is being conducted in order to evaluate objective change in cognition and expressive language after implant and therapy with the Inspire UAS System.
Neurology
NCT04729907
In this study, researchers will learn more about the use of nusinersen (BIIB058) in participants with spinal muscular atrophy (SMA).
Neurology
NCT04530110
The primary objective of the study is to evaluate the long-term safety and tolerability of subcutaneous fremanezumab in the preventive treatment of migraine in pediatric participants 6 to 17 years of age (inclusive at enrollment in the pivotal study).
Neurology
Quantification of N-acetylglucosamine-asparagine (GlcNAc-Asn) in the brain using MR Spectroscopy in non Aspartylglucosaminuria patients
To quantify Glcnac-asn in brain cells in non aspartylglucosaminuria patients * To identify useful biomarkers and clinical outcome measures for future treatment studies * To evaluate the relationship of Glcnac-asn in aGu and controls to clinical severity
Neurology
NCT03678753
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, adjunctive therapy study in subjects with PGTC seizures.
Neurology
NCT05626855
The ONYX study is an Open-Label, Multicenter, Extension study that will evaluate the long-term safety and efficacy of Apitegromab in Patients with Type 2 and Type 3 SMA who have completed TOPAZ or SAPPHIRE.
Neurology
NCT04446442
The purpose of this research study is to investigate the effects of transcranial direct current stimulation (tDCS) on some of the challenges faced by children with autism Spectrum Disorder (aSD).